glp-1 digital health platforms startups What's next for innovation: A primer on the race reshaping pharma and chronic disease care Quantum Health Launches New GLP-1
Description
Vickers, A

The FDA has documented dosing-error harms with compounded injectable semaglutide and warns specifically against salt forms (semaglutide sodium, semaglutide acetate) different active ingredients than the base form used in approved drugs

Weight loss with tirzepatide 15 mg was 11.2 kg compared to 5.7 kg with semaglutide, nearly double

Mild nausea GLP-1 medications slow stomach emptying, which means food may stay in the stomach longer than usual

These same states report obesity rates near or above 40%, among the highest in the country
Another study found that exendin-4 pushes immune cells to switch toward an anti inflammatory phenotype while cutting down the harmful pro inflammatory phenotype, and that came along with better hindlimb motor function